In a second approach, we looked for combined expression of the established sarcoma marker TLE1 with vimentin in CD45- cells in another panel of sarcoma patients, demonstrating the ability to identify putative CTCs present in much higher numbers than the median number of presumptive false positive cells in the healthy donor population. The gene discussed is TLE1; the disease is sarcoma.